Professor Geoff Strange has 20 years of clinical and medical affairs leadership experience within the hospital setting as well as the pharmaceutical and medical device industries internationally. From an academic point of view, Geoff has more than 75 professional publications including books, peer review publications and abstracts presented at international scientific meetings.
Geoff was appointed as Professor in the School of Medicine, University of Notre Dame in 2018, where he is responsible for curriculum development, with a specific interest in pulmonary hypertension, congenital heart disease (CHD) and big imaging data.
Geoff is the current and founding Chief Executive Officer of the Pulmonary Hypertension Society of Australia and New Zealand. Geoff is also the Managing Director of Mozaic Solutions Pty Ltd., a company set up to meet varying needs for medical professionals, pharmaceutical and device companies in clinical research, medical writing, medical marketing and key thought leader engagement and relationship management.
Geoff is also currently a member of the Department of Cardiology research team at Royal Prince Alfred Hospital, Sydney Australia working directly for Prof David Celermajer.
Geoff has a keen interest in CHD and has recently set up the first Australian and New Zealand Adult CHD Consortium, responsible for the first adult ANZ CHD and PAH patient registry. This network includes the majority of medical specialists focused on adult CHD across Australia and New Zealand.